CSL Bulk Human Coagulation Factor VIII 500 IU (50 IU/mL) / von Willebrand factor 1200 IU powder for injection vial

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

Von willebrand factor, Quantity: 1200 IU; Factor VIII, Quantity: 500 IU

제공처:

CSL Behring Australia Pty Ltd

INN (국제 이름):

Factor VIII,Von willebrand factor

약제 형태:

Injection, powder for

구성:

Excipient Ingredients: sodium citrate dihydrate; trometamol; calcium chloride dihydrate; Albumin; sucrose; sodium chloride

관리 경로:

Intravenous

치료 징후:

von Willebrand disease (VWD) - Treatment of haemorrhage or prevention and treatment of surgical bleeding in patients with VWD, when desmopressin (DDAVP) treatment alone is ineffective or contraindicated. Haemophilia A (congenital FVIII deficiency) - Prophylaxis and treatment of bleeding in patients with haemophilia A.

제품 요약:

Visual Identification: A white or pale yellow, hygroscopic powder or friable solid; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2013-09-02